David M. Gershenson
@RareOvarCancers
Followers
502
Following
12
Media
0
Statuses
20
Highlighting research advances and news about rare ovarian cancers: clear cell, low-grade serous, mucinous, malignant germ cell tumors, sex cord-stromal tumors
MD Anderson Cancer Center
Joined August 2011
Rare Ovarian Cancer Awareness Read more: https://t.co/ICi4ZuL0aM
#OvarianCancer
healthprofessionalradio.com.au
Dr. David Gershenson discusses ovarian cancer and a rare form called low-grade serous ovarian cancer (LGSOC).
0
1
6
One Strikeout, One Hit Against Low-Grade Serous Carcinomas https://t.co/jfJOtSr1mi via @medscape
medscape.com
Two MEK inhibitors were tested against recurrent low-grade serous carcinomas of the ovaries, fallopian tubes, or peritoneum, but only one offered clinical benefit over standard care, say researchers.
0
1
8
KRAS May Predict Benefit of MEK Inhibitors in Some Ovarian Cancers
medpagetoday.com
Nearly 7-month PFS boost in patients with KRAS mutations
0
1
8
#Powerfulvoices from #lowgradeserous #ovariancancer woman around the world, for World Ovarian Cancer Day. #WOCD2020 Donate to research to help women live longer at https://t.co/jZ8iK790Q7
0
9
11
You go to a hospital and don’t wear a mask!? What a jerk! You need to re-evaluate your values and concern for others!
0
0
10
Trametinib Boosts PFS and Response Rates in Low-Grade Ovarian Cancer https://t.co/MzH9HCGhfY via @onclive
0
0
2
Trametinib Tx Shows Promise in Tough-to-Treat LGSOC
medpagetoday.com
Targeted drug provokes good response in chemoresistant, low-grade serous ovarian or peritoneal cancer
0
1
6
Hormone Therapy Prolongs PFS in Low-grade Serous Cancer https://t.co/eQokxsy1yQ via @medscape
0
0
2
Largest study to date demonstrates the activity of bevacizumab in low-grade serous carcinoma
pubmed.ncbi.nlm.nih.gov
Bevacizumab, most often in combination with chemotherapy, has activity in recurrent low-grade ovarian cancer and should be considered a treatment option for these patients. Further investigation into...
0
1
2
"What We Know and What We Need to Know About Neoadjuvant Chemotherapy in Advanced Ovarian Cancer" https://t.co/RF7fj0G6dJ via @ascopost
0
1
1
Serous borderline ovarian tumors with BRAF mutations less likely to recur as low-grade serous cancer #ovariancancer
http://t.co/5Q8FkrNGOC
0
0
1
Article reports Norwegian experience with ovarian germ cell tumors. Message: They should be treated at major centers. http://t.co/xv8dR9TjzL
0
0
2
This is a new twitter site in which I will be disseminating scientific advances and news about rare ovarian cancers. Check it out. DMG
0
0
2